WebSep 26, 2024 · The public meeting, conducted as an all-day video call on November 6, 2024, concerned the application for aducanumab, a drug that would be marketed under the name Aduhelm by the company Biogen ... WebApr 10, 2024 · Biogen already cut as many as 885 positions globally in 2024, based on securities filings. Executives had originally planned to eliminate more than 1,000 in wake of disappointing sales of Aduhelm ...
The Petri Dish: Ex-Biogen MS head joins Inozyme; Moderna hits …
WebApr 11, 2024 · Cambridge, Mass.— Biogen Inc . (Nasdaq:BIIB) today announced it will report first quarter 2024 financial results Tuesday, April 25, 2024, before the financial markets open. Following the release of the financials, the Company will host a live webcast with Biogen management at 8:00 a.m. ET. WebApr 11, 2024 · A Look At Biogen's Liabilities. We can see from the most recent balance sheet that Biogen had liabilities of US$3.27b falling due within a year, and liabilities of US$7.89b due beyond that. spot check lancaster pa
More layoffs hit Biogen as drugmaker cuts multiple …
WebWelcome to Biogen's digital hub for US Healthcare Professionals — providing access to tools and resources to help support your patients on Biogen therapies. Biogen … WebJun 7, 2024 · The FDA approved Biogen's Alzheimer's disease drug aducanumab. It's the first drug cleared by U.S. regulators to slow cognitive decline in people living with … http://media.biogen.com/news/news-releases spot check for gold today